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Uncoupling IL-2 Signals that Regulate T Cell
Proliferation, Survival, and Fas-Mediated
Activation-Induced Cell Death
these are regulated at a molecular level. The IL-2 recep-
tor is a heterotrimeric receptor, composed of a high-
affinity cytokine binding subunit (IL-2R a chain, CD25)
and two signaling components, the IL-2 receptor b chain
and the common receptor g chain (gc) that is shared
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with the IL-4, IL-7, IL-9, and IL-15 receptors (TaniguchiPasadena, California 91125
and Minami, 1993; Leonard, 1996). These receptor² Immunology Research Division
chains activate cytokine-specific signaling pathways,Department of Pathology
such as those transduced by the activation of JanusBrigham and Women's Hospital
kinases (Jaks) and signal transducers and activators ofand Harvard Medical School
transcription (Stats), as well as general signaling path-Boston, Massachusetts 02115
ways, that are implicated in cell proliferation and differ-³Virginia Mason Research Center
entiation (Ihle et al., 1995; Taniguchi, 1995; Leonard andand Department of Immunology
O'Shea, 1998). IL-2 has been shown to activate Jak1,University of Washington
Jak3, and Stat5 (Hatakeyama et al., 1991; Miyazaki etSeattle, Washington 98195
al., 1994; Russell et al., 1994; Fujii et al., 1995). The IL-2
receptor also recruits the adapter protein Shc, linking it
to the Ras/MAP kinase and PI-3 kinase/Akt pathwaysSummary
(Johnston et al., 1995; Friedmann et al., 1996; Lord et
al., 1998; J. D. L. and B. N., unpublished data). However,IL-2 is an important growth and survival factor for T
it remains unclear what role these different signalinglymphocytes but also sensitizes these cells to Fas-
pathways play in the regulation of IL-2 function andmediated activation-induced cell death (AICD). The
especially in the regulation of AICD, in primary T cells.molecular basis of these different effects of IL-2 was
A major hurdle in addressing this question is the diffi-studied by introducing wild-type and mutant forms of
culty associated with manipulating gene function in pri-the IL-2 receptor b (IL-2Rb) chain that lacked specific
mary lymphocytes. We have recently developed a retro-signaling capacities into receptor-deficient T cells by
virus-based method for expressing genes in primaryretroviral gene transfer. Activation of Stat5 by IL-2 was
lymphocytes (L. V. P., unpublished data). Here, we re-found to be involved in T cell proliferation and promoted
port on the IL-2 responses and sensitivity to apoptosisFas ligand (FasL) expression and AICD. T cell survival
of activated IL-2Rb2/2 T cells that are reconstitutedwas dependent on a receptor region that activated Akt
with wild-type or mutant versions of the human IL-2Rband the expression of Bcl-2. Thus, distinct IL-2Rb chain
(hIL-2Rb).signaling modules regulate T cell fate by stimulating
growth and survival or by promoting apoptosis.
Results
Introduction Expression of IL-2Rb Mutants in Primary IL-2Rb2/2
T Cells by Retrovirus-Mediated Gene Transfer
IL-2 plays a critical role in the regulation of immune To identify IL-2-induced signals that regulate T cell pro-
responses. It is an important growth factor for T cells liferation or apoptosis, we used a retrovirus-based ap-
following stimulation by antigen and also functions to proach to express wild-type and mutant forms of the
promote T cell survival, probably by inducing the expres- human IL-2Rb (hIL-2Rb) chain in primary T cells from
sion of Bcl-2 and related proteins (Smith, 1988; Miyazaki IL-2Rb-deficient mice. We chose to study receptor mu-
et al., 1995; Akbar et al., 1996; Van Parijs et al., 1997; tants, called D355 or Y338F, that are individually defec-
Lord et al., 1998). However, mice that lack IL-2 or a tive in either Stat5 or Akt activation because these mole-
functional IL-2 receptor (IL-2R) accumulate activated T cules had previously been implicated in the regulation
cells and develop autoimmunity (Sadlack et al., 1993; of T cell proliferation and survival (Friedmann et al., 1996;
Suzuki et al., 1995; Willerford et al., 1995), suggesting Ahmed et al., 1997; Brennan et al., 1997; Fujii et al.,
that the dominant role of IL-2 in vivo is to terminate T 1998; Moriggl et al., 1999). In the point mutant Y338F
cell responses and to maintain tolerance. A possible (Figure 1), tyrosine 338 has been replaced with a phenyl-
mechanistic explanation of this function is provided by alanine residue. This tyrosine is required for Shc binding
the observation that IL-2 renders activated T cells suscep- (Friedmann et al., 1996; Ravichandran et al., 1996; Lord
tible to AICD (Lenardo, 1991; Van Parijs et al., 1997; Refaeli et al., 1998), and we have found that Y338F fails to
et al., 1998), a pathway of cell death that serves to eliminate activate Akt (Figure 2). The D355 mutant (Figure 1; Lord
autoreactive T cells (Van Parijs and Abbas, 1998). et al., 1998) lacks the C-terminal hIL-2Rb H region, as
Given the physiological importance of the different well as part of the hIL-2Rb A region, but retains tyrosine
and opposing effects of IL-2, a major question is how 338. This receptor fails to activate Stat5 (Figure 2). Both
mutations are present in the double mutant, D35518F,
which does not activate Stat5 or Akt (Figure 2).§ To whom correspondence should be addressed (e-mail: baltimo@
To introduce the IL-2Rb chain mutants into primary Tcaltech.edu).
‖ These authors contributed equally to this work. cells, their cDNAs were cloned into a retrovirus expression
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Figure 1. Reconstitution of IL-2Rb-Deficient
T Cells with hIL-2Rb Mutants
(A) Structure of the hIL-2Rb mutants used in
this study. EC, extracellular domain; TM,
transmembrane domain. Intracellular domains
assigned as described (Hatakeyama et al.,
1989).
(B) Structure of the pMIG vector used to gen-
erate retroviruses. LTR, long terminal repeat;
IRES, internal ribosomal entry site; GFP,
green fluorescent protein.
(C) Flow cytometric analysis of IL-2Rb-defi-
cient T cells infected with the parental retrovi-
rus (Vector) or retroviruses expressing hIL-2Rb
mutants. The percentage of double-positive
(GFP- and hIL-2Rb expressing) cells is indi-
cated.
vector (Figure 1). This retrovirus is a modified version the green fluorescent protein (GFP). Purified CD41 T
cells were activated with antibodies to CD3 and CD28,of the murine stem cell virus ([MSCV], Hawley et al.,
1994). It expresses a bicistronic messenger RNA encod- in the presence of IL-4, and simultaneously infected
with retroviruses. Using this approach, we can routinelying both the test protein and, as a marker of infection,
transduce 60%±90% of cultured wild-type T cells, as
gauged by GFP expression (see JGP 1). The level of
infection obtained with IL-2Rb-deficient cells was typi-
cally less than this (20%±40% in 20 independent experi-
ments) (Figure 1) because these cells proliferated less
vigorously, and cells must be cycling for integration of
the virally encoded genes to occur. Importantly, infected
IL-2Rb2/2 T cells showed comparable surface expres-
sion of the wild-type and mutant hIL-2Rb proteins (Fig-
ure 1). To confirm that all four transduced receptors were
biologically active, we demonstrated that they were all
able to phosphorylate Jak1, which only requires mem-
brane proximal Box 1 and Box 2 of the IL-2Rb chain
(Figure 2; Miyazaki et al., 1994).
Regulation of T Cell Proliferation by IL-2
We first sought to define the signaling requirements
for IL-2-mediated proliferation of T cells. Wild-type and
IL-2Rb2/2 T cells were activated for 3 days and infected
with hIL-2Rb-expressing retroviruses. At the time that
the cells were harvested for analysis, more than 70%
of the infected (GFP1) knockout T cells expressed de-
tectable amounts of IL-2Ra (data not shown). In compar-
ison, nearly 100% of the infected wild-type cells were
IL-2Ra positive. To assess their ability to proliferate, the
activated cells were then cultured in the presence of
IL-2 or IL-4. Wild-type, but not IL-2Rb-deficient, T cells
Figure 2. Signaling Properties of the hIL-2Rb Mutants in Primary T proliferated in response to IL-2, whereas both cell types
Cells
responded to IL-4 (Figure 3). Activated IL-2Rb2/2 T cells
(A) Jak1 activation in reconstituted IL-2Rb-deficient T cells. Jak1 expressing wild-type hIL-2Rb (WT) regained the ability
was immunoprecipated from infected T cells that had been treated
to proliferate in response to either murine or human IL-2with IL-2 for 2 hr and analyzed by Western blot with an antibody to
(Figure 3; data not shown). Both the D355 and Y338Fphosphotyrosine (top panel) or to Jak1 (bottom panel).
(B) Akt activation in reconstituted IL-2Rb-deficient T cells. Infected mutants were still able to support IL-2-mediated prolifer-
T cells were treated for 12 hr with IL-2 and analyzed by Western ation (Figure 3), indicating that individually these signal-
blot with an antibody to phospho-Akt (S473) (top panel) or to Akt ing modules are not critical for the growth-inducing
(bottom panel). function of IL-2 in activated T cells. However, the double
(C) Stat5 activation in reconstituted T cells. Nuclear extracts were
mutant, D35518F, did not rescue proliferation, estab-obtained from infected T cells that had been treated with IL-2 for 2
lishing that at least one of these signaling moduleshr and tested for their ability to bind an ªoptimalº Stat5 binding
probe (Wang et al., 1996a) in an electrophoretic mobility shift assay. needs to be intact for IL-2 to drive T cells into cycle.
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These results correlate IL-2-mediated T cell survival with
a receptor motif that activates Akt. Importantly, this
IL-2R motif is not redundant with the Stat5-activating
module for the antiapoptotic activity of IL-2.
One consequence of IL-2 signaling through Y338 is
the induction of Bcl-2 expression (Figure 4; Lord et al.,
1998). To test whether the decreased expansion and
survival of IL-2Rb2/2 cells reconstituted with Y338F
could be rescued by this molecule, we coinfected
IL-2Rb2/2 T cells with two retroviruses, one expressing
an hIL-2Rb mutant, the other human Bcl-2 (hBcl-2). The
hBcl-2 retrovirus was constructed to express human
placental alkaline phosphatase (PLAP) off a bicistronic
transcript (Refaeli et al., 1998), so that we could simulta-
Figure 3. Proliferation of Reconstituted IL-2Rb-Deficient T Cells to neously monitor for hIL-2Rb (GFP) and hBcl-2 (PLAP)IL-2 and IL-4
expression (Figure 4). Because we used replication-
Infected T cells were cultured for 48 hr with increasing concentra-
defective retroviruses, we were able to adjust the titer oftions of IL-2 (left panel) or 1000 U/ml of IL-4 (right panel) and pulsed
both viruses so that most infected cells expressed bothwith 3H-thymidine for the last 6 hr of the assay. To control for differ-
GFP and PLAP. Singly (hIL-2Rb only) and doubly (hIL-ences in the efficiency of retroviral infection between groups, the
scintillation counts obtained (counts per minute [CPM]) were divided 2Rb and hBcl-2) infected IL-2Rb2/2 T cells were cultured
by the number of GFP positive (infected) cells in each well and in the presence of IL-2 for 5 days, after which the number
are expressed as CPM/GFP positive cells. Results are from one of viable, hIL-2Rb-expressing (GFP1) cells was deter-
representative experiment of four performed.
mined. As shown in Figure 4, retrovirus-mediated ex-
pression of hBcl-2 increased the number of viable cells
recovered in all groups. Importantly, hBcl-2 synergizedRegulation of Cell Survival by IL-2
with proliferative signals from the mutant Y338F hIL-In the next set of experiments, we examined which IL-2
2Rb chain to restore the number of viable IL-2Rb2/2 Tsignals were necessary to sustain T cell expansion and
cells to the level seen with WT or D355 hIL-2Rb. Thus,survival. When treated with IL-2, activated wild-type T
retrovirus-mediated Bcl-2 expression can compensatecells continued to expand and remained viable up to 5
for IL-2-induced survival signals that require Y338.days in vitro (Figure 4). In contrast, IL-2Rb-deficient cells
rapidly became apoptotic. hIL-2Rb mutants that sup-
ported proliferation (WT, Y338F, and D355) also pro- Potentiation of Fas-Mediated AICD and FasL
Expression by IL-2moted T cell expansion up to 3 days. After this time,
however, cells expressing the Y338F mutant became Finally, we examined the contribution of IL-2-induced
signals to the regulation of AICD. Activated T cells un-apoptotic, and the total number of viable cells in Y338F
cultures decreased. IL-2Rb knockout cells reconstituted dergo this form of cell death when they are repeatedly
stimulated with antigen or antibodies to the T cell recep-with WT or D355 remained viable and continued to
expand, suggesting that Stat5 is not required for tor and express high levels of FasL (Van Parijs and Ab-
bas, 1996). Consistent with a role for IL-2 in AICD (Len-IL-2-mediated survival of T cells (Figure 4). In agreement
with this, activated Stat5-deficient T cells did not suc- ardo, 1991; Van Parijs et al., 1997; Refaeli et al., 1998),
activated IL-2Rb-deficient T cells were less susceptiblecumb to apoptosis when cultured with IL-2 (Table 1).
Figure 4. IL-2 Signals that Regulate T Cell
Survival
(A) IL-2-mediated expansion and survival of
reconstituted T cells. Infected T cells were
cultured with IL-2 for 5 days. The number
of viable, GFP positive (infected) cells was
determined daily by counting and flow cytom-
etry. Results are shown as percentage of in-
put cell number and are from one representa-
tive experiment of two performed.
(B) Bcl-2 induction in reconstituted IL-2Rb-
deficient T cells. Infected T cells were treated
for 12 hr with IL-2 and analyzed by Western
blot with an antibody to Bcl-2 (top panel) or
to b-actin (bottom panel).
(C) Effect of Bcl-2 expression on the expan-
sion and survival of reconstituted T cells. In-
fected T cells were cultured with IL-2 for 5
days. The number of viable, GFP positive (in-
fected) cells was determined by counting and
flow cytometry. Results are shown as percentage of input cell number and are from one representative experiment of two performed.
(D) Flow cytometric analysis of IL-2Rb-deficient T cells coinfected with retroviruses expressing hIL-2Rb mutants (GFP) or hBcl-2 (PLAP). The
percentage of double-positive (GFP- and PLAP-expressing) cells is indicated for one representative group.
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Table 1. Regulation of T Cell Function by Specific IL-2 Signals
IL-2Rb-Deficient T Cells Stat5-Deficient T Cells
Transduced Molecule None (Vector) WT Y338F D355 D35518F None (Vector) Stat5WT CD25
Stat5 activity 2 1 1 2 2 2 1 2
Akt activity 2 1 2 1 2 1 1 1
Proliferation to IL-2 2 1 1 1 2 2 1 2
Proliferation to IL-4 1 1 1 1 1 1 1 1
Promotes survival 2 1 2 1 2 1 1 ND
Promotes AICD 2 1 1 2 2 2 1 ND
Activated IL-2Rb- or Stat5-deficient T cells were infected with retroviruses expressing the indicated molecules and cultured for 20 hr to
determine if they activated Stat5 or Akt. Proliferation was assessed after 48 hr of culture with 50 U/ml IL-2 or 1000 U/ml IL-4. A positive score
reflects a greater than 3-fold increase in proliferative index over background. Survival was assessed after 5 days of culture with 50 U/ml IL-2.
A positive score was given when cultures yielded at least the same number of viable cells at day 3 and day 5 of culture. AICD was assessed
after 20 hr of culture in the presence of 0.1 mg/ml of plate-bound anti-CD3 and 50 U/ml IL-2. A positive score reflects a greater than 3-fold
increase in cell death compared with cultures without anti-CD3. ND, not determined.
than wild-type cells to this form of cell death when stimu- with the D355 or the D35518F mutants were significantly
lower. This result implicates Stat5 in the regulation oflated with anti-CD3 (Figure 5). Sensitivity to AICD was
conferred on cells by expression of WT or Y338F hIL- FasL expression and provides a mechanistic explana-
tion for the reduction in AICD observed in the absence2Rb. In contrast, T cells reconstituted with receptor mu-
tants that failed to activate Stat5 (D355 and D35518F) of Stat5 activation. To confirm that Stat5 is directly in-
volved in regulating FasL expression and AICD in acti-remained largely resistant to AICD (Figure 5). Thus, the
activation of this form of cell death by IL-2 is regulated vated T cells and to exclude a contribution of other signals
that might derive from the C terminus of the hIL-2Rb chain,by a specific receptor module and can be uncoupled
from proliferation and survival in activated T cells. We we cultured activated Stat5-deficient T cells with in-
creasing doses of anti-CD3. As shown in Figure 6,have previously shown that IL-2 increases the expres-
sion of FasL on T cells (Refaeli et al., 1998). This is a Stat5a/b2/2 T cells showed a reduced sensitivity to AICD
that could be rescued by retrovirus-mediated expres-critical event in AICD since T cells derived from FasL-
deficient gld mice do not undergo this form of cell death, sion of full-length Stat5a (Stat5WT). The double-knock-
out T cells also showed lower expression of FasL follow-even when activated in the presence of IL-2 (data not
shown). To test whether T cells expressing IL-2Rb mu- ing TCR cross-linking (Figure 6).
To examine whether Stat5 plays a role in AICD oftants that did not rescue sensitivity to AICD might be
defective in FasL induction, we assayed the levels of normal T cells, wild-type T cells were activated and in-
fected with retroviruses expressing full-length (Stat5WT)this molecule on reconstituted T cells stimulated with
anti-CD3. IL-2Rb2/2 cells expressing WT hIL-2Rb or the or dominant-negative Stat5 (Stat5D713), which lacks the
C-terminal transactivating domain (see JPG 1; Wang etY338F mutant showed increased FasL surface protein
following TCR cross-linking (Figure 5). However, under al., 1996a). This resulted in robust expression of these
molecules as determined by Western blot and gel shiftthe same culture conditions, the levels of FasL in cells
Figure 5. Activation-Induced Cell Death and
FasL Expression of Reconstituted IL-2Rb-
Deficient T Cells
(A) AICD of reconstituted T cells. Infected T
cells were cultured for 20 hr in the presence of
IL-2 and increasing concentrations of plate-
bound anti-CD3. The percentage of viable,
GFP positive (infected) cells was determined
by flow cytometry. Results are from one rep-
resentative experiment of six performed.
(B) Expression of FasL on reconstituted T
cells stimulated with anti-CD3. Infected T
cells were cultured for 8 hr in the presence
of IL-2 and 0.1 mg/ml of plate-bound anti-
CD3. The level of FasL on infected cells was
determined by gating on GFP positive cells.
Anti-CD3-induced levels of FasL are repre-
sented by filled histograms, resting levels by
empty histograms. The following groups are
shown: IL-2Rb-deficient T cells infected with
the parental retrovirus or a retrovirus ex-
pressing hIL-2Rb WT, the Y338F mutant, the
hIL-2Rb D355 mutant, or the double mutant
D35518F, as well as wild-type T cells infected
with the parental retrovirus.
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significant efforts have been made to understand the
biochemical basis of this function. Our results show that
hIL-2Rb modules that activate either Stat5 or Akt can
mediate proliferation of previously activated T cells but
that neither pathway is essential. This observation is in
agreement with a previous report describing the
IL-2-induced proliferation of primary T cells expressing
mutant versions of the murine IL-2Rb chain (Fujii et al.,
1998). A recent study using Stat5-deficient T cells, how-
ever, suggests that this transcription factor plays an
indispensable role in T cell proliferation (Moriggl et al.,
1999). We too have found that Stat5a/b2/2 cells are de-
fective in IL-2-mediated growth, even after they have
been fully activated by stimulation with anti-CD3 and
IL-4 (Table 1; data not shown). It is unclear why experi-
ments with T cells expressing receptors lacking the
Stat5 activation domain and with cells from Stat5-defi-
cient mice provide different answers to the question of
the role of this molecule in IL-2-dependent proliferation
of T cells. It is possible that the mutant receptors still
activate low levels of Stat5 and so promote T cell growth.
However, by gel shift and Western blot analysis we do
not detect activation of this transcription factor by the
mutant receptors in primary T cells (Figure 2; data not
shown; Fujii et al., 1998). Alternatively, Stat5 might have
Figure 6. Activation-Induced Cell Death and FasL Expression of a role in T cell proliferation that is independent of the C
Stat5-Deficient T Cells terminus of the IL-2Rb chain. A number of recent studies
(A) AICD of Stat5a/b2/2 T cells. Infected T cells were cultured for have suggested that Stat5 might have a direct effect on
20 hr in the presence of IL-2 and increasing concentrations of plate- IL-2-mediated proliferation of T cells by regulating the
bound anti-CD3. The percentage of viable, GFP positive (infected)
expression of the IL-2Ra chain (CD25) (Nakajima et al.,cells was determined by flow cytometry. Results are from one repre-
1997; Fujii et al., 1998). However, we were unable tosentative experiment of three performed.
rescue IL-2-mediated proliferation of Stat5-deficient T(B) Expression of FasL on Stat5a/b2/2 T cells stimulated with anti-
CD3. Infected wild-type or Stat5-deficient T cells were cultured for cells by retroviral expression of CD25 (Table 1; data not
6 hr in the presence of IL-2 and 0.1 mg/ml of plate-bound anti-CD3. shown). This suggests that the Stat5-deficient T cells
The level of FasL on infected cells was determined by gating on have defects in cell cycling that lie downstream of recep-
GFP positive cells. Anti-CD3-induced levels of FasL are represented
tor expression (Imada et al., 1998; Moriggl et al., 1999).by filled histograms, resting levels by empty histograms. The follow-
Although in vitro experiments consistently point to aing groups are shown: Stat5-deficient T cells infected with the paren-
critical role for IL-2 in T cell growth, in vivo studies havetal retrovirus or with a retrovirus expressing wild-type Stat5a.
shown that T cells can respond to antigen in the absence
of this cytokine (Kundig et al., 1993; Khoruts et al., 1998).
assays (see JPG 1). Dominant-negative but not wild- Thus, other growth factors must be able to support T
type Stat5 reduced the sensitivity of T cells to AICD (see cell activation and expansion in vivo. Prime candidates
JPG 2). We also tested the expression of FasL in anti- for this function are cytokines that are related to IL-2
CD3-stimulated T cells expressing Stat5WT or Stat5D713. and also use the gc chain, such as IL-4, IL-7, and IL-15.
The upregulation of FasL was defective in cells expressing In the case of IL-4, the signals for T cell growth do not
dominant-negative but not wild-type Stat5 (see JPG 2), appear to include Stat5, since we have found that Stat5-
again demonstrating that Stat5 regulates expression of deficient cells proliferate in response to this cytokine
this molecule. (Table 1; data not shown). Stat5-independent pathways
of T cell proliferation can be initiated through the recruit-
Discussion ment and activation of molecules that express a PTB
domain, including Shc and IRS1/2 (Wang et al., 1993;
In this study, we have examined the relationship be- Keegan et al., 1994; Lord et al., 1998). The Stat5-inde-
tween signaling modules in the IL-2Rb chain and the pendent proliferation induced by IL-2Rb and dependent
multiple functions of IL-2 in primary T lymphocytes. To on Y338 presumably works in this manner. These adap-
this end, a retroviral gene transfer system was used to tor molecules couple cytokine receptors multiple signal-
reconstitute T cells derived from IL-2Rb2/2 mice with ing pathways, including the PI-3 kinase and Ras/MAP
wild-type and mutant forms of this receptor chain. Our kinase pathways. It remains unclear what downstream
results support a model for IL-2 function in T cells where targets of these pathways are required for proliferation,
survival of activated cells and AICD are controlled by but recent studies support roles for c-myc, Akt, and
the activation of specific signaling modules within the Pyk2, among others. (Miyazaki et al., 1995; Ahmed et
IL-2Rb chain that both have the ability to stimulate prolif- al., 1997; Brennan et al., 1997; Miyazaki et al., 1998).
eration. IL-2 also promotes T cell survival (Miyazaki et al.,
IL-2 was originally described as the major growth fac- 1995). This function has been attributed to the ability of
this cytokine to induce anti-apoptotic Bcl family proteinstor for T cells (Smith, 1988), and, as a consequence,
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(Akbar et al., 1996). Here, we show that tyrosine 338 of et al., 1993; Suzuki et al., 1995; Willerford et al., 1995).
the IL-2Rb chain is essential to the survival of T cells, Furthermore, expression of an IL-2Rb chain lacking the
while Stat5 activation is dispensable. Y338 is required Stat5-activating domain cures the lymphadenopathy
for the activation of Akt and the induction of Bcl-2 by seen in IL-2Rbko mice, suggesting that Stat5 may not
IL-2 in T cells. The antiapoptotic function of Bcl-2 is well be required for this role of the IL2R (Fujii et al., 1998).
documented (Adams and Cory, 1998), and we demon- It is not known whether other symptoms of autoimmunity
strate that retroviral expression of Bcl-2 can rescue the are also cured in these mice. Further analysis of mice
expansion and survival of T cells expressing the Y338F with selective defects in IL-2 signaling should help clarify
IL-2Rb chain mutant. It is not clear whether Akt blocks the mechanisms by which this cytokine regulates self-
apoptosis entirely by regulating the expression of Bcl tolerance.
family proteins (Ahmed et al., 1997) or whether it also The results presented here demonstrate that the dis-
functions in a parallel pathway by inhibiting the activity tinct effects of IL-2 on T cells are induced by specific
of proapoptotic molecules and caspases (Datta et al., IL-2Rb chain signaling motifs. It is important to consider
1997; del Peso et al., 1997; Cardone et al., 1998). We how the sum of these signals might determine the fate
have found that retroviral expression of an activated of a T cell, especially since the IL-2R induces both pro-
form of Akt in primary T cells is sufficient for their survival and antiapoptotic signals. One possibility is that the
while a dominant-negative form of this molecule reduces level of receptor engagement determines which signals
the viability of cells cultured in the presence of IL-2 are triggered. In support of a ªthresholdº model for IL-2
(L. V. P. and D. B., unpublished data). Also, receptor signaling, we have found that lower levels of this cyto-
motifs that activate Akt have been implicated in T cell kine tend to promote T cell survival whereas higher lev-
survival by IL-4 and other cytokines that are related to els are required to induce AICD (Y. R. and A. K. A.,
IL-2 (Nelms et al., 1999). Thus, the antiapoptotic function unpublished data). According to this model, T cells re-
of IL-2 and related cytokines is probably mediated by sponding to antigen in the presence of low levels of IL-2
a conserved, Akt-dependent mechanism that can be would expand while high concentrations of IL-2 would
mimicked by Bcl-2 overexpression. result in T cell death. Alternatively, the outcome of IL-2R
Although other cytokines can induce T cell prolifera- engagement might be determined by signals derived
tion and promote survival, IL-2 appears to be uniquely from other surface receptors. These receptors would
potent at sensitizing T cells to AICD (Willerford et al., regulate the level of molecules that inhibit or promote
1995; Wang et al., 1996b; Van Parijs et al., 1997; Zheng specific functions of IL-2. According to this ªintegratedº
et al., 1998). A mechanistic basis for this observation is model for IL-2 signaling, IL-2 would prime T cells to die
suggested here by the demonstration that IL-2-medi- following antigen encounter unless they also received
ated activation of Stat5 plays a role in potentiating AICD. a signal that blocks AICD, e.g., by upregulating the anti-
We show that Stat5 activation increases the expression apoptotic molecule, FLIP (Irmler et al., 1997; Refaeli et
of FasL following T cell receptor cross-linking, which al., 1998; L. V. P. and D. B., unpublished data). Future
is a critical event during the induction of this type of studies are needed for a complete description of how
apoptosis (Van Parijs and Abbas, 1996). Preliminary IL-2 regulates T cell fate.
studies have shown that the FasL promoter contains
a Stat5 binding site (Y. R., unpublished data). We are Experimental Procedures
currently analyzing the role of this promoter sequence in
IL-2 regulated FasL expression and AICD. Interestingly, Mice
Wild-type and IL-2Rb-deficient C57BL/6 mice (Suzuki et al., 1995)significant similarities exist between the organization of
were obtained from the Jackson Laboratory and were genotypedthe promoters for FasL and CD25, both of which require
by PCR as described (Suzuki et al., 1995). Stat5a/b double-knockoutStat5 and TCR engagement for prolonged, high-level
mice were obtained from Dr. J. Ihle (St. Jude's Children's Hospital,expression (Nabholz et al., 1995; Refaeli et al., 1998;
Memphis, TN).
Zheng et al., 1998). Thus, Stat5 synergizes with TCR-
derived signals to regulate the expression of molecules T Cell Purification and Activation
that in turn regulate both T cell expansion and apoptosis. CD41 T cells were purified from the spleen and lymph nodes of
In the absence of IL-2-induced Stat5 activation, TCR wild-type or IL-2Rb-deficient mice using CD41 Dynal beads (Dynal,
Oslo, Norway) and Detachabead anti-CD4 antibody (Dynal, Oslo,cross-linking stimulates low levels of FasL and AICD
Norway), as described (Refaeli et al., 1998), and activated with 1(Figures 5 and 6; Refaeli et al., 1998; Zheng et al., 1998).
mg/ml anti-CD3 and anti-CD28 (PharMingen) and 1000 U/ml IL-4A second function of IL-2 that is not shared by related
(Genzyme).cytokines is its role in regulating the activation of autore-
active T cells (Sadlack et al., 1993; Suzuki et al., 1995;
Retroviral Plasmid Construction and T Cell Infections
Willerford et al., 1995). Our findings here raise the possi- The retroviral expression vector, pMIG, was created by placing GFP
bility that activation of Stat5 by IL-2 may be involved in downstream of the pCITE1 IRES (Novagen) and cloning it into the
the maintenance of self-tolerance by promoting acti- EcoRI and SalI sites of the MSCV 2.2 vector (Hawley et al., 1994),
vated T cells to undergo AICD. This hypothesis is sup- replacing the neomycin-resistance gene expressed in the original
vector. The cDNAs encoding wild-type and mutant human IL-2Rb,ported by the observation that mice lacking both Stat5a
Stat5 (from J. Ihle), and CD25 (from D. Willerford, University of Wash-and Stat5b accumulate activated T cells in the spleen
ington, Seattle, WA) were then cloned into this vector. The cDNA(Moriggl et al., 1999), indicating that they may have a
for human Bcl-2 (from G. Nunez, University of Michigan, Ann Arbor,
defect in antigen-dependent elimination of peripheral T MI) was cloned into pMIP (Refaeli et al., 1998) . Retroviruses were
cells. However, these mice do not develop autoantibod- generated by transfecting Bosc 23 cells with 10 mg of plasmid DNA
ies, which is a feature of the autoimmunity that develops according to the protocol of Pear et al. (1993). Retrovirus-containing
Bosc cell supernatant was collected 48 and 72 hr after transfectionin mice lacking IL-2 or the IL-2Ra or b chain (Sadlack
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